“One of our clients is a married couple with about $5 million in liquid assets. They are both 80 years old. 90% of their money is in equities. Most in US large cap index funds and then they own large single positions in Nvidia, Eli Lilly, and Tesla. The husband wants to be 100% in these things. The wife wants it all in CDs. Trying to walk them back from so much risk would seem easy but because the husband has been ‘right’ recently, it has been difficult.” -Financial Advisor & KCR Subscriber
We do not envy the Financial Advisors who face such challenges. However, the feedback we received after our last piece, The Great Growth Run & a Peek at Forsaken Dividend Stocks, suggests these challenges are increasingly common for FAs. We received several requests to walk through the case for dividend stocks.[1]
Get our insights direct to your inbox: SUBSCRIBE
Over the next several pages, we are going to present the historical evidence that suggests today may be an opportune time to consider shifting out of growth and into dividend-paying stocks. Our goal is to make the case in simple and straightforward language and charts.
The chart below shows the percentage of the large-cap universe that has paid a dividend since the 1960s.[2] For index fund investors, your exposure to stocks that pay you dividends has only been lower at the peak of the dot.com bubble and the prior peak in December of 2021. For some, this may be reason enough to consider adding some dedicated dividend exposure. For others, we’ll move to the next page.
The chart below shows you the return owners of the S&P 500 achieved by decade, starting in 1960. For each decade, we have broken out the returns attributable to the change in stock prices vs. the returns from dividends. The bars are assembled as follows:
- First bar: returns generated by dividends
- Second bar: returns generated by price appreciation
- Third bar: the total return for the decade
Disclaimer
The information, data, analyses, and opinions presented herein (a) do not constitute investment advice, (b) are provided solely for informational purposes and therefore are not, individually or collectively, an offer to buy or sell a security, (c) are not warranted to be correct, complete or accurate, and (d) are subject to change without notice. Kailash Capital Research, LLC and its affiliates (collectively, “KCR”) shall not be responsible for any trading decisions, damages, or other losses resulting from, or related to, the information, data, analyses or opinions or their use. The information herein may not be reproduced or retransmitted in any manner without the prior written consent of KCR. In preparing the information, data, analyses, and opinions presented herein, KCR has obtained data, statistics, and information from sources it believes to be reliable. KCR, however, does not perform an audit or seek independent verification of any of the data, statistics, and information it receives. KCR and its affiliates do not provide tax, legal, or accounting advice. This material has been prepared for informational purposes only and is not intended to provide, and should not be relied on for tax, legal, or accounting advice. You should consult your tax, legal, and accounting advisors before engaging in any transaction.
Nothing herein shall limit or restrict the right of affiliates of KCR to perform investment management or advisory services for any other persons or entities. Furthermore, nothing herein shall limit or restrict affiliates of KCR from buying, selling, or trading securities or other investments for their own accounts or for the accounts of their clients. Affiliates of KCR may at any time have, acquire, increase, decrease, or dispose of the securities or other investments referenced in this publication. KCR shall have no obligation to recommend securities or investments in this publication as a result of its affiliates’ investment activities for their own accounts or for the accounts of their clients.
© 2023 Kailash Capital Research, LLC – All rights reserved.
February 7, 2024 |
| Authors: Matthew Malgari, Nathan Przybylo, Dr. Sanjeev Bhojraj and John Durkin
February 7, 2024
Authors: Matthew Malgari, Nathan Przybylo, Dr. Sanjeev Bhojraj and John Durkin